Cowealth Medical China Co.,Ltd. (SHA:603122)
8.57
-0.63 (-6.85%)
At close: Nov 20, 2026
Cowealth Medical China Market Cap
Cowealth Medical China has a market cap or net worth of 3.41 billion as of November 20, 2026. It is the 13,539th most valuable company in the world and the 3,422nd biggest in China. Its market cap has decreased by 63.99% in one year.
Market Cap
3.41B
Enterprise Value
3.31B
Revenue
640.00M
Global Rank
Country Rank
#3,422 China
PE Ratio
n/a
ChartMarket Cap Chart
Since February 16, 2022, Cowealth Medical China's market cap has increased from 2.40B to 3.41B, an increase of 42.12%. That is a compound annual growth rate of 7.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.41B | -64.88% |
| Dec 31, 2025 | 9.71B | 248.07% |
| Dec 31, 2024 | 2.79B | -12.92% |
| Dec 29, 2023 | 3.20B | -28.13% |
| Dec 30, 2022 | 4.46B | 85.74% |
| Feb 16, 2022 | 2.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Strong Biotechnologies,Inc. | 7.00B |
| Amoy Diagnostics | 6.29B |
| Shanghai Runda Medical Technology | 4.42B |
| Medicalsystem Biotechnology | 3.22B |
| Shanghai Labway Clinical Laboratory | 3.20B |
| Guangdong Hybribio Biotech | 2.93B |
| Thalys Medical Technology Group | 2.73B |
| Berry Genomics Co.,Ltd | 2.64B |